{
    "2021-03-19": [
        [
            {
                "time": "2021-04-05",
                "original_text": "What Scott Gottlieb Thinks About The Heated Exchange Between Anthony Fauci And Rand Paul",
                "features": {
                    "keywords": [
                        "Scott Gottlieb",
                        "Anthony Fauci",
                        "Rand Paul",
                        "heated exchange"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-06",
                "original_text": "Biden’s vaccine goal was not a ‘moonshot challenge’: Analyst",
                "features": {
                    "keywords": [
                        "Biden",
                        "vaccine goal",
                        "moonshot challenge",
                        "analyst"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-07",
                "original_text": "Janssen's Ponvory Wins FDA Nod For Relapsing Multiple Sclerosis",
                "features": {
                    "keywords": [
                        "Janssen",
                        "Ponvory",
                        "FDA",
                        "relapsing multiple sclerosis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-08",
                "original_text": "UPDATE 2-U.S. FDA approves J&J's multiple sclerosis treatment; launch in April",
                "features": {
                    "keywords": [
                        "FDA",
                        "J&J",
                        "multiple sclerosis",
                        "treatment",
                        "launch"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-09",
                "original_text": "Biden Administration Nears Goal of Administering 100 Million Vaccines",
                "features": {
                    "keywords": [
                        "Biden Administration",
                        "vaccines",
                        "goal",
                        "100 million"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-10",
                "original_text": "Could a Supply Glut Sink COVID Vaccine Stocks?",
                "features": {
                    "keywords": [
                        "supply glut",
                        "COVID",
                        "vaccine stocks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}